Crinetics Pharmaceuticals, Inc. (NasdaqGM: CRNX)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Crinetics Pharmaceuticals, Inc. (NasdaqGM: CRNX) operates in the Pharmaceuticals industry within the Health Care sector.
trading between 32.30 and 85.01.
Tweenvest scores Crinetics Pharmaceuticals, Inc. across four factors: quality 39/100, value 78/100, growth 100/100. Its strongest factor is growth.
CRNX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $42.16M
- P/E
- —
- EPS
- -5.03
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $85.01
- 52-week low
- $32.30
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 594
- Next earnings
- —
About Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flagship drug candidate, Paltusotine, is an orally administered, selective, non-peptide somatostatin receptor type 2 agonist. This compound has concluded its Phase III clinical trials for the treatment of acromegaly, and has also completed Phase II trials targeting carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). Furthermore, the company's pipeline includes CRN04777, an oral selective non-peptide somatostatin type 5 receptor agonist, which is currently undergoing Phase I clinical trials for congenital hyperinsulinism. Another investigational drug, CRN04894, an oral adrenocorticotrophic hormone antagonist, is in Phase I clinical trials for Cushing's disease and congenital adrenal hyperplasia. Crinetics Pharmaceuticals, Inc. was founded in 2008 and maintains its headquarters in San Diego, California.
- ISIN
- US22663K1079
- Founded
- 2008
- Listed since
- Jul 18, 2018
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Regnum Corp.OTCPK: RGMP | $23.00 | $0.00 | — |
| CanaQuest Medical Corp.OTCPK: CANQ.F | $21.00 | $— | — |
| The Greenrose Holding Company Inc.OTCPK: GNRS.Q | $18.00 | $0.00 | — |
| Lowell Farms Inc.OTCPK: LOWL.F | $18.00 | $— | — |
| West Island Brands Inc.OTCPK: WIBF.F | $17.00 | $— | — |
| BioELife Corp.OTCPK: LITH | $9.00 | $— | — |
| BC Craft Supply Co. Ltd.OTCPK: CRFT.F | $2.00 | $— | — |
| Virpax Pharmaceuticals, Inc.OTCPK: VRPX | $1.00 | $0.00 | — |
Figures last refreshed Sep 20, 2026.